{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:57:08Z","timestamp":1790636228639,"version":"4.1.0"},"reference-count":42,"publisher":"Stanford University Press","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,4,26]],"date-time":"2017-04-26T00:00:00Z","timestamp":1493164800000},"content-version":"vor","delay-in-days":176,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Mass Spectrometry"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.clinms.2016.08.001","type":"journal-article","created":{"date-parts":[[2016,9,21]],"date-time":"2016-09-21T15:25:59Z","timestamp":1474471559000},"page":"11-18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["LC\u2013MS\/MS application for urine free pyridinoline and free deoxypyridinoline: Urine markers of collagen and bone degradation"],"prefix":"10.21627","volume":"1","author":[{"given":"Jonathan C.Y.","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Dutton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Piec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darrell","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0611-4220","authenticated-orcid":false,"given":"Christopher J.","family":"Washbourne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0556-3358","authenticated-orcid":false,"given":"William D.","family":"Fraser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4811","reference":[{"issue":"Suppl. 6","key":"10.1016\/j.clinms.2016.08.001_b0005","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1007\/s001980070002","article-title":"The use of biochemical markers of bone turnover in osteoporosis. Committee of Scientific Advisors of the International Osteoporosis Foundation","volume":"11","author":"Delmas","year":"2000","journal-title":"Osteoporos. Int."},{"issue":"4","key":"10.1016\/j.clinms.2016.08.001_b0010","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/jbmr.5650100418","article-title":"Different effects of bisphosphonate and estrogen therapy on free and peptide-bound bone cross-links excretion","volume":"10","author":"Garnero","year":"1995","journal-title":"J. Bone Miner. Res."},{"issue":"5","key":"10.1016\/j.clinms.2016.08.001_b0015","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/jbmr.5650080516","article-title":"Immunoassay of pyridinoline crosslink excretion in normal adults and in Paget\u2019s disease","volume":"8","author":"Delmas","year":"1993","journal-title":"J. Bone Miner. Res."},{"issue":"2","key":"10.1016\/j.clinms.2016.08.001_b0020","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/S0003-2697(03)00241-0","article-title":"High-performance liquid chromatography method to analyze free and total urinary pyridinoline and deoxypyridinoline","volume":"318","author":"Vesper","year":"2003","journal-title":"Anal. Biochem."},{"issue":"1","key":"10.1016\/j.clinms.2016.08.001_b0025","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1136\/ard.62.1.65","article-title":"Evaluation of free and peptide bound collagen crosslink excretion in different skeletal diseases","volume":"62","author":"M\u00fcller","year":"2003","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.clinms.2016.08.001_b0030","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0169-6009(91)90143-N","article-title":"Urinary excretion of pyridinium crosslinks: a new marker of bone resorption in metabolic bone disease","volume":"8","author":"Uebelhart","year":"1990","journal-title":"Bone Miner."},{"issue":"3","key":"10.1016\/j.clinms.2016.08.001_b0035","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1093\/oxfordjournals.jbchem.a131983","article-title":"Pyridinoline, a non-reducible crosslink of collagen. Quantitative determination, distribution, and isolation of a crosslinked peptide","volume":"83","author":"Fujimoto","year":"1978","journal-title":"J. Biochem."},{"issue":"2","key":"10.1016\/j.clinms.2016.08.001_b0040","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/0006-291X(80)90347-2","article-title":"The hydroxypyridinium crosslinks of skeletal collagens: their measurement, properties and a proposed pathway of formation","volume":"92","author":"Eyre","year":"1980","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.clinms.2016.08.001_b0045","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0003-2697(88)90274-6","article-title":"Quantitative analysis of the pyridinium crosslinks of collagen in urine using ion-paired reversed-phase high-performance liquid chromatography","volume":"169","author":"Black","year":"1988","journal-title":"Anal. Biochem."},{"issue":"1","key":"10.1016\/j.clinms.2016.08.001_b0050","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/10826069908544694","article-title":"Method for the isolation and purification of pyridinoline and deoxypyridinoline crosslinks from bone by liquid chromatographic techniques","volume":"29","author":"Meddah","year":"1999","journal-title":"Prep. Biochem. Biotechnol."},{"issue":"5\u20136","key":"10.1016\/j.clinms.2016.08.001_b0055","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jchromb.2010.12.024","article-title":"UPLC methodology for identification and quantitation of naturally fluorescent crosslinks in proteins: a study of bone collagen","volume":"879","author":"Sroga","year":"2011","journal-title":"J. Chromatogr. B: Anal. Technol. Biomed. Life Sci."},{"issue":"9","key":"10.1016\/j.clinms.2016.08.001_b0060","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1373\/clinchem.2008.105262","article-title":"Automated HPLC assay for urinary collagen cross-links: effect of age, menopause, and metabolic bone diseases","volume":"54","author":"Kraenzlin","year":"2008","journal-title":"Clin. Chem."},{"issue":"26","key":"10.1016\/j.clinms.2016.08.001_b0065","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1016\/j.jchromb.2011.07.044","article-title":"Simultaneous free and glycosylated pyridinium crosslink determination in urine: validation of an HPLC-fluorescence method using a deoxypyridinoline homologue as internal standard","volume":"879","author":"Monticelli","year":"2011","journal-title":"J. Chromatogr. B: Anal. Technol. Biomed. Life Sci."},{"issue":"6","key":"10.1016\/j.clinms.2016.08.001_b0070","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1365-2265.1995.tb02687.x","article-title":"Urinary pyridinoline and deoxypyridinoline excretion in children","volume":"42","author":"Shaw","year":"1995","journal-title":"Clin. Endocrinol. (Oxf.)"},{"issue":"1","key":"10.1016\/j.clinms.2016.08.001_b0075","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1164\/ajrccm.149.1.8111578","article-title":"Effect of diet on urinary excretion of desmosine and hydroxylysyl pyridinoline","volume":"149","author":"Stone","year":"1994","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.clinms.2016.08.001_b0080","series-title":"IMMULITE 2000 PYRILINKS-D for the Quantitative Measurement of Deoxypyridinoline (DPD) in Urine [Package Insert]","year":"2007"},{"key":"10.1016\/j.clinms.2016.08.001_b0085","series-title":"MicroVue Deoxypyridinoline (DPD) Enzyme Immunoassay Kit for the Quantitation of Crosslinks in Human Urine [Package Insert]","year":"2009"},{"key":"10.1016\/j.clinms.2016.08.001_b0090","series-title":"MicroVue Enzyme Immunoassay Kit for the Quantitation of Pyridinium Crosslinks in Urine [Package Insert]","year":"2015"},{"issue":"1","key":"10.1016\/j.clinms.2016.08.001_b0095","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1006\/abio.2000.4625","article-title":"Quantitative method for biomarkers of collagen degradation using liquid chromatography tandem mass spectrometry","volume":"283","author":"Kindt","year":"2000","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.clinms.2016.08.001_b0100","series-title":"Governance Arrangements for Research Ethics Committees: A Harmonised Edition","year":"2011"},{"key":"10.1016\/j.clinms.2016.08.001_b0105","series-title":"Guidance for Industry Bioanalytical Method Validation","author":"Kadavil","year":"2013"},{"key":"10.1016\/j.clinms.2016.08.001_b0110","series-title":"Guideline on Bioanalytical Method Validation","year":"2012"},{"issue":"3","key":"10.1016\/j.clinms.2016.08.001_b0115","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/clinchem\/27.3.493","article-title":"A multi-rule Shewhart chart for quality control in clinical chemistry","volume":"27","author":"Westgard","year":"1981","journal-title":"Clin. Chem."},{"issue":"19","key":"10.1016\/j.clinms.2016.08.001_b0120","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.jchromb.2010.03.039","article-title":"Quantification of immature and mature collagen crosslinks by liquid chromatography-electrospray ionization mass spectrometry in connective tissues","volume":"878","author":"Gineyts","year":"2010","journal-title":"J. Chromatogr. B: Anal. Technol. Biomed. Life Sci."},{"issue":"1\u20132","key":"10.1016\/j.clinms.2016.08.001_b0125","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0009-8981(02)00338-8","article-title":"Search for new urinary biochemical markers of collagen degradation in man","volume":"327","author":"Roth","year":"2003","journal-title":"Clin. Chim. Acta"},{"issue":"3","key":"10.1016\/j.clinms.2016.08.001_b0130","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S8756-3282(97)00279-2","article-title":"Collagen cross-links in mineralizing tissues: a review of their chemistry, function, and clinical relevance","volume":"22","author":"Knott","year":"1998","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.clinms.2016.08.001_b0135","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1080\/08869634.2003.11746230","article-title":"Changes in urinary bone resorption markers (pyridinoline, deoxypyridinoline) resulting from experimentally-induced osteoarthritis in the temporomandibular joint of rats","volume":"21","author":"Imada","year":"2003","journal-title":"Cranio"},{"issue":"4","key":"10.1016\/j.clinms.2016.08.001_b0140","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/00041552-199907000-00005","article-title":"Biochemical markers of bone turnover","volume":"8","author":"Hart","year":"1999","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"issue":"6","key":"10.1016\/j.clinms.2016.08.001_b0145","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.bone.2008.08.123","article-title":"Sex steroids and bone turnover markers in men with symptomatic vertebral fractures","volume":"43","author":"Tuck","year":"2008","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.clinms.2016.08.001_b0150","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/00365510310000475","article-title":"Pyridinoline cross-links as markers for primary and secondary bone tumors","volume":"63","author":"Behrens","year":"2003","journal-title":"Scand. J. Clin. Lab. Invest."},{"issue":"1","key":"10.1016\/j.clinms.2016.08.001_b0155","first-page":"55","article-title":"Diagnostic value of urine deoxypyridinoline for detecting bone metastases in breast cancer patients","volume":"33","author":"Hou","year":"2003","journal-title":"Ann. Clin. Lab. Sci."},{"issue":"10","key":"10.1016\/j.clinms.2016.08.001_b0160","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1002\/cncr.10522","article-title":"The clinical use of bone resorption markers in patients with malignant bone disease","volume":"94","author":"Coleman","year":"2002","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.clinms.2016.08.001_b0165","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1007\/BF03347524","article-title":"Elevated bone resorption markers in a patient with hypercalcemia associated with post-partum thyrotoxicosis and hypoadrenocorticism due to pituitary failure","volume":"27","author":"Fujikawa","year":"2004","journal-title":"J. Endocrinol. Invest."},{"issue":"2","key":"10.1016\/j.clinms.2016.08.001_b0170","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1046\/j.1365-2265.1997.2401045.x","article-title":"Antithyroid therapy improves bony manifestations and bone metabolic markers in patients with Graves\u2019 thyrotoxicosis","volume":"47","author":"Nagasaka","year":"1997","journal-title":"Clin. Endocrinol. (Oxf.)"},{"issue":"8","key":"10.1016\/j.clinms.2016.08.001_b0175","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.3899\/jrheum.121392","article-title":"Serum pyridinoline levels and prediction of severity of joint destruction in rheumatoid arthritis","volume":"40","author":"Krabben","year":"2013","journal-title":"J. Rheumatol."},{"issue":"1","key":"10.1016\/j.clinms.2016.08.001_b0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2478\/v10039-009-0003-x","article-title":"Urinary bone resorption markers (deoxypyridinoline and C-terminal telopeptide of type I collagen) in healthy persons, postmenopausal osteoporosis and patients with type I diabetes","volume":"54","author":"Fassbender","year":"2009","journal-title":"Adv. Med. Sci."},{"issue":"4","key":"10.1016\/j.clinms.2016.08.001_b0185","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.0904-2512.2004.00097.x","article-title":"Utility of urinary pyridinoline and deoxypyridinoline ratio for diagnosis of osteoarthritis at temporomandibular joint","volume":"33","author":"Tanimoto","year":"2004","journal-title":"J. Oral Pathol. Med."},{"issue":"3","key":"10.1016\/j.clinms.2016.08.001_b0190","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1093\/tropej\/47.3.186","article-title":"Urinary free deoxypyridinoline assessment in recognition of rickets","volume":"47","author":"Soylu","year":"2001","journal-title":"J. Trop. Pediatr."},{"issue":"2","key":"10.1016\/j.clinms.2016.08.001_b0195","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/ajmg.a.30529","article-title":"Nevo syndrome is allelic to the kyphoscoliotic type of the","volume":"133A","author":"Giunta","year":"2005","journal-title":"Am. J. Med. Genet. A"},{"issue":"11","key":"10.1016\/j.clinms.2016.08.001_b0200","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1002\/ajh.21856","article-title":"Urinary markers of bone resorption, pyridinoline and deoxypyridinoline, are increased in sickle cell patients with further increments during painful crisis","volume":"85","author":"Nur","year":"2010","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.clinms.2016.08.001_b0205","series-title":"GeneReviews(R)","article-title":"Ehlers\u2013Danlos Syndrome, Kyphoscoliotic Form","author":"Yeowell","year":"1993"},{"issue":"6","key":"10.1016\/j.clinms.2016.08.001_b0210","first-page":"1505","article-title":"Urinary pyridinoline cross-links in Ehlers\u2013Danlos syndrome type VI","volume":"57","author":"Steinmann","year":"1995","journal-title":"Am. J. Hum. Genet."}],"container-title":["Clinical Mass Spectrometry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2376999816300083?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2376999816300083?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T03:47:29Z","timestamp":1770263249000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2376999816300083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":42,"alternative-id":["S2376999816300083"],"URL":"https:\/\/doi.org\/10.1016\/j.clinms.2016.08.001","relation":{},"ISSN":["2376-9998"],"issn-type":[{"value":"2376-9998","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"LC\u2013MS\/MS application for urine free pyridinoline and free deoxypyridinoline: Urine markers of collagen and bone degradation","name":"articletitle","label":"Article Title"},{"value":"Clinical Mass Spectrometry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinms.2016.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Association for Mass Spectrometry: Applications to the Clinical Lab (MSACL). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}